Maplelane Capital’s Bausch Health BHC Stock Holding History

Maplelane Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1	Closed	–	–	98
2015 Q4	$0	Hold	1	–	–	﹤0.01%	104
2015 Q3	$0	Buy	+1	New	+$233	﹤0.01%	97

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Maplelane Capital's BHC Position: Q1 2016 in Review

Maplelane Capital sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 1 share.

Maplelane Capital first reported a position in BHC in Q3 2015 and held it in 2 quarters. The position peaked at $0 in Q4 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Maplelane Capital reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Maplelane Capital sold 1 Bausch Health share in Q1 2016.
Maplelane Capital first reported a position in Bausch Health in Q3 2015 and held it in 2 quarters.
Maplelane Capital's Bausch Health position peaked at $0 in Q4 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Maplelane Capital's 13F filing for Q1 2016, filed 16 May 2016.